TLR4 and metabolic dysfunction-associated steatotic liver disease: Indeed, once reaching the liver, LPS is known to bind receptors such as toll-like receptor 4 (TLR-4), releasing inflammatory mediators, and thus contributing to liver inflammation and NAFLD progression [13].